0920-0666 CDC 57.1 AUR - Pharmacy Electronic Upload - Remdesivir

Form Approved

OMB No. 0920-0666

Exp. Date: 12/31/22

Antimicrobial Use and Resistance (AUR): Pharmacy Data

Monthly Electronic Upload Specification Tables

These data will be collected in an aggregate monthly electronic file transfer from the facility to NHSN via Clinical Document Architecture (CDA).

Table 1. CDA File Descriptors

These data elements will be transmitted with each month’s report.

Variable Name

Description of Variable

Facility OID

NHSN Facility ID number

Application OID

Vendor software ID number

SDS validation ID

ID provided by NHSN Team confirming vendor software passed validation

location

NHSN location code

month

Denominator month

year

Denominator year

Table 2. Aggregate Patient Information

These data elements are aggregated to the location and facility wide inpatient level for each month.

Variable Name

Description of Variable

numDaysPresent

Total number of days present

numTherapyDays

Number of therapy days

numAdmissions

Number of admissions

Table 3. Aggregate Pharmacy Information

These data elements are obtained from the facility’s electronic medication administration record (eMAR) or bar coding medication administration (BCMA) and aggregated to the location and facility wide inpatient level for each month.

Variable Name

Description of Variable

Examples

drugIngredient

Antimicrobial ingredient

(see Table 3a)

routeDrugAdmin

Route of administration

Digestive tract, respiratory tract, intravenous route, intramuscular route

Table 3a. List of Antimicrobials Accepted

This is the list of antimicrobials currently accepted into NHSN as part of the antimicrobial use reporting.

Amantadine

Aztreonam

Cefpodoxime

Clarithromycin

Fidaxomicin

Meropenem/ Vaborbactam

Penicillin V

Telavancin

Amikacin

Caspofungin

Cefprozil

Clindamycin

Fluconazole

Metronidazole

Peramivir

Tetracycline

Amikacin Liposomal

Baloxavirmarboxil

Ceftaroline

Colistimethate

Fosfomycin

Micafungin

Piperacillin/ Tazobactam

Tigecycline

Amoxicillin

Cefaclor

Ceftazidime

Colistin

Gemifloxacin

Minocycline

Plazomicin

Tinidazole

Amoxicillin/ Clavulanate

Cefadroxil

Ceftazidime/ Avibactam

Dalbavancin

Gentamicin

Moxifloxacin

Polymyxin B

Tobramycin

Amphotericin B

Cefazolin

Ceftolozane/ Tazobactam

Daptomycin

Imipenem/ Cilastatin

Nafcillin

Posaconazole

Vancomycin

Amphotericinlipid complex B

Cefdinir

Cefiderocol

Delafloxacin

Isavuconazonium

Nitrofurantoin

Quinupristin/ Dalfopristin

Voriconazole

Amphotericin B liposomal

Cefepime

Ceftriaxone

Dicloxacillin

Itraconazole

Omadacycline

Relebactamcilastatin with Imipenem/

Zanamivir

Ampicillin

Cefixime

Cefuroxime

Doxycycline

Lefamulin

Oritavancin

Rifampin

Ampicillin/ Sulbactam

Cefotaxime

Cephalexin

Eravacycline

Levofloxacin

Oseltamivir

Rimantadine

Anidulafungin

Cefotetan

Chloramphenicol

Ertapenem

Linezolid

Oxacillin

Sulfamethoxazole/ Trimethoprim

Azithromycin

Cefoxitin

Ciprofloxacin

Erythromycin

Meropenem

Penicillin G

Tedizolid

Assurance of Confidentiality: The voluntarily provided information obtained in this surveillance system that would permit identification of any individual or institution is collected with a guarantee that it will be held in strict confidence, will be used only for the purposes stated, and will not otherwise be disclosed or released without the consent of the individual, or the institution in accordance with Sections 304, 306 and 308(d) of the Public Health Service Act (42 USC 242b, 242k, and 242m(d)). Public reporting burden of this collection of information is estimated to average 5 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC, Reports Clearance Officer, 1600 Clifton Rd., MS D-74, Atlanta, GA 30333 ATTN: PRA (0920-0666). CDC 57.124 v6, 10.0

Page 5 of 5